Ask AI
ProCE Banner Activity

Up-to-Date Treatment Recommendations for Moderate to Severe Psoriasis

Clinical Thought

Review expert recommendations on latest treatment in moderate to severe psoriasis care and learn strategies for using shared decision-making to help inform patients about their treatment options, including how disease severity, comorbidities, and current data affect their options.

Released: June 25, 2025

Expiration: June 24, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC

ProCE Banner

Supporters

Supported by educational grants from Lilly and Sun Pharmaceutical Industries, Inc

Lilly

Sun Pharmaceutical Industries, Inc.

Partners

Practicing Clinicians Exchange, LLC

ProCE Banner

Disclosure

Primary Author

Benjamin Ungar, MD: consultant/advisor/speaker: AbbVie, Arcutis, Botanix, Bristol Myers Squibb, Fresenius Kabi, Galderma, Johnson & Johnson, LEO Pharma, Lilly, Pfizer, Primus, Sanofi, UCB; researcher (paid to institution): Incyte, Rapt, Sanofi.